Aging
Navigate
Submit an Article
Research Paper|Volume 13, Issue 16|pp. 20661–20683
METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas
Back to articleFigure 5(5 of 9)
100%
Figure 5
Figure 5.KEGG and GO analysis of DEGs between low and high METTL21B expression groups. KEGG analysis of DEGs (A, B); GO analysis of DEGs (C, D).